Follow Us
https://www.thebody.com/author/johns-hopkins-aids-service

Latest by Johns Hopkins AIDS Service

Promo Image

Profiles on New Drugs

Index

Indinavir Ritonavir Saquinavir Lamivudine (3TC) Amphotericin B Lipid Complex Liposomal Daunorubicin

IndinavirTrade name: Crixivan (Merck Research Laboratories)Form: 100, 200 and 400 mg capsules.Clinical trials: Phase I/II trials sho...

Promo Image

The Moving Target of Antiretroviral Therapy

The FDA approved 3TC (Lamivudine) and saquinavir in November, 1995, and then approved ritonavir and indinavir on March 1, 1996. This sudden expansion of the armamentarium of drugs for HIV is viewed as a major breakthrough for HIV therapeutics. It i...

Promo Image
News

Profiles on New Drugs

Index

Indinavir Ritonavir Saquinavir Lamivudine (3TC) Amphotericin B Lipid Complex Liposomal Daunorubicin

IndinavirTrade name: Crixivan (Merck Research Laboratories)Form: 100, 200 and 400 mg capsules.Clinical trials: Phase I/II trials sho...